One of the biggest waves in healthcare now is the care and treatment of the aging population. Among the more common maladies we face as we get...
All we've heard for the last month or so is how the market is undergoing a tremendous rotation between sectors.
The migration of money...
A tiny $7 company has developed a breakthrough solution that could protect 50 million American men from the ravages of prostate...
On June 28, Amazon.com Inc. (NASDAQ: AMZN) announced the acquisition of PillPack, an online pharmacy company that ships prescriptions directly to...
The Dow Jones news today will focus on rising stocks as Dow Jones futures are up 103 points this morning.
International markets are...
Our top pharmaceutical stocks to buy are all expected to have double-digit gains, making now a great time to buy.
With new drugs on the...
Johnson & Johnson news sees two analysts bringing down JNJ stock by more than 1% in the past five trading days.
The pullback comes after...
These five pharmaceutical penny stocks to watch for August 2017 have made gains of as much as 50% in the last 30 days.
But don't let these...
This pharmaceutical stock to buy is undervalued compared to its peers.
A big reason why this stock is undervalued is that analysts...
The pharmaceutical industry is expected to see spending in the sector double in the next few years.
The best pharmaceutical stock in...
Despite the recent negative news, Insys Therapeutics stock is still a great buy.
Even better for investors is the fact that it has an...
Our expert has developed a vetting process to identify the best pharmaceutical stocks to buy in 2017.
One of the stocks he picked using...
Once again, a Big Pharma company has rewarded its top execs at the expense of shareholders...
Mylan overcharged the government (a.k.a....
Valeant stock has risen 46% so far this month, but we still can't find a good reason to buy.
The company is still struggling from its...
Big pharma execs are hoping to avoid President Trump's wrath by drastically reducing the amount of price hikes in 2017.
Producers...
Thanks in part to notorious "Pharma Bro" Martin Shkreli, the U.S. feds caught wind of one very bad pharmaceutical apple....
Some of the most outrageous drug price increases of 2016 have placed huge burdens on patients and caregivers alike. According to an Oct. 11 report...
The 21st Century Act seems to benefit patients by expediting the drug approval process, but it fails to address one key...
The Valeant stock price surged more than 25% this week after the firm released Q2 earnings.
But shares of VRX are down nearly 10% again...
Big-cap investors were profoundly underwhelmed when the Obama administration caused Pfizer Inc. to cancel a $150 billion buyout of...
